XM

Xavier Mesnier

Principal France & UK at Verve Ventures

Lausanne, Vaud

Overview 

Xavier Mesnier is currently serving as the TechBio & Deeptech VC at Verve Ventures, focusing on private investments and venture capital in sectors like DeepTech and Digital Health. With a background in R&D and project management, Xavier has successfully invested in companies like Orakl Oncology and has held key roles at Nitto Denko Technical Corporation and NATUREX, showcasing a strong track record in the food technology and health industries.

Work Experience 

VV

Verve Ventures

  • Partner - Head of Health & Bio investments

    2025 - Current

    Investments include: - Orakl Oncology (Fr) - Case45 (UK) - Axiom Therapeutics (UK) - Inoviv (UK) - Limula (CH) - Poppins (Fr) - Multiomic.health (UK) - Cell Voyant (UK) - Therapixel (Fr) - Cambrian Biopharma (USA)

  • Principal

    2022 - 2025

    Lead investor Techbio and Future of Computing at Verve Ventures

  • Investment Manager - France

    2020 - 2022

  • Associate

    2018 - 2019

ND

Nitto Denko Technical Corporation

  • Intrapreneur in Health & Bio

    2015 - 2017

N

NATUREX

  • Scientific Coordinator

    2013 - 2015

Uo

University of Sheffield

  • PhD Chemical & Biological Engineering

    2009 - 2013

NS

Nestle S.A.

  • Master thesis

    2008 - 2009

    Carried out at the Nestle Research Centre in Switzerland

Bonne Maman

  • Process Engineer

    2008 - 2008

Education 

Investments 

Orakl Oncology

Seed

Total funding: $3M

Articles About Xavier

Relevant Websites